Found: 19
Select item for more details and to access through your institution.
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E353, doi. 10.1002/ajh.26274
- By:
- Publication type:
- Article
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. E183, doi. 10.1002/ajh.25480
- By:
- Publication type:
- Article
Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. E166, doi. 10.1002/ajh.24773
- By:
- Publication type:
- Article
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E105, doi. 10.1002/ajh.24715
- By:
- Publication type:
- Article
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 511, doi. 10.1002/ajh.23999
- By:
- Publication type:
- Article
Decrease in circulating dendritic cells predicts fatal outcome in septic shock.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 7, p. N.PAG, doi. 10.1007/s11095-019-2605-8
- By:
- Publication type:
- Article
Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patients.
- Published in:
- Annales de Biologie Clinique, 2023, v. 81, n. 4, p. 379, doi. 10.1684/abc.2023.1826
- By:
- Publication type:
- Article
Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia.
- Published in:
- 2007
- By:
- Publication type:
- Other
The Necrotic Signal Induced by Mycophenolic Acid Overcomes Apoptosis-Resistance in Tumor Cells.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005493
- By:
- Publication type:
- Article
Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 175, doi. 10.1111/bjh.15784
- By:
- Publication type:
- Article
Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 558, doi. 10.1111/bjh.15690
- By:
- Publication type:
- Article
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 462, doi. 10.1111/bjh.14324
- By:
- Publication type:
- Article
Actualités dans la leucémie lymphoïde chronique Quelques temps forts du congrès 2021de la Société française d'hématologie.
- Published in:
- Hematologie, 2021, v. 27, n. 6, p. 262, doi. 10.1684/hma.2021.1695
- By:
- Publication type:
- Article
Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion.
- Published in:
- Journal of Leukocyte Biology, 2023, v. 113, n. 3, p. 305, doi. 10.1093/jleuko/qiad006
- By:
- Publication type:
- Article
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 987, doi. 10.1007/s00277-021-04419-w
- By:
- Publication type:
- Article